menu
    • menu

    Company profile for Kubota Pharmaceutical

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kubota Pharmaceutical Holdings and its subsidiary Kubota Vision Inc. are committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kubota Pharmaceuticaljapan Flag
    Country
    Country
    Japan
    Address
    Address
    Kasumigaseki Tokyu Building 4F, 3-7-1 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013
    Telephone
    Telephone
    +81.3.6550.8928
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kubotaholdings.co.jp/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kubota Vision Announces Collaboration Agreement with Leading Diabetes Center
    Kubota Vision Announces Collaboration Agreement with Leading Diabetes Center

    29 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220929005312/en

    BUSINESSWIRE
    29 Sep 2022
    Share Share
    Kubota Vision Initiates PBOS Prospective Study in Patients
    Kubota Vision Initiates PBOS Prospective Study in Patients

    17 Jan 2022

    // PRESS RELEASE

    https://www.kubotaholdings.co.jp/en/ir/docs/20220117_EN_kagoshima_final2.pdf

    PRESS RELEASE
    17 Jan 2022
    Share Share
    Kubota Vision Receives ISO 13485:2016 Certification
    Kubota Vision Receives ISO 13485:2016 Certification

    18 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211018005238/en

    BUSINESSWIRE
    18 Oct 2021
    Share Share
    Kubota Vision Announces Publication of Emixustat’s Pharmacodynamic Effects
    Kubota Vision Announces Publication of Emixustat’s Pharmacodynamic Effects

    24 Nov 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201124005350/en

    BUSINESSWIRE
    24 Nov 2020
    Share Share
    Kubota Vision Announces Signing of Open Innovation Agreement with LEO Pharma A/S
    Kubota Vision Announces Signing of Open Innovation Agreement with LEO Pharma A/S

    16 Apr 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200416005261/en

    BUSINESSWIRE
    16 Apr 2020
    Share Share
    Acucela Provides Update on Emixustat Ph3 Trial Patients with Stargardt Disease
    Acucela Provides Update on Emixustat Ph3 Trial Patients with Stargardt Disease

    13 Feb 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200213005034/en

    BUSINESSWIRE
    13 Feb 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search